Workflow
Innovation Medical(002173)
icon
Search documents
创新医疗股价上涨10.03% 特大单净流入4.81亿元
Sou Hu Cai Jing· 2025-08-05 10:12
Company Overview - As of August 5, 2025, the stock price of Innovation Medical is reported at 16.23 yuan, an increase of 1.48 yuan from the previous trading day [1] - The opening price for the day was 14.96 yuan, with a highest price of 16.23 yuan and a lowest price of 14.75 yuan [1] - The trading volume reached 1,050,309 hands, with a total transaction amount of 1.637 billion yuan [1] - The company is primarily engaged in medical services and is registered in Zhejiang Province [1] Market Activity - On that day, there was a net inflow of large orders amounting to 481 million yuan for Innovation Medical, ranking it among the top in the Shanghai and Shenzhen stock markets [1] - In contrast, the overall pharmaceutical and biotechnology industry is experiencing a trend of capital outflow, with a net outflow of large orders totaling 3.362 billion yuan [1]
6.79亿主力资金净流入,脑机接口概念涨2.72%
Market Performance - The brain-computer interface concept rose by 2.72%, ranking third among concept sectors, with 27 stocks increasing in value [1][2] - Notable gainers included Innovation Medical, ST Huaton, and Aipeng Medical, which surged by 13.97%, 7.52%, and 7.40% respectively [1][2] Capital Flow - The brain-computer interface sector saw a net inflow of 679 million yuan, with 21 stocks receiving net inflows, and 6 stocks exceeding 30 million yuan in net inflow [2][3] - Innovation Medical led the net inflow with 472 million yuan, followed by ST Huaton and Aipeng Medical with 146 million yuan and 55 million yuan respectively [2][3] Stock Performance - The top stocks by net inflow ratio included Innovation Medical at 28.82%, followed by Jiahe Intelligent at 9.74% and Entropy Technology at 8.96% [3] - Other notable performers included ST Huaton with a 5.03% increase and Aipeng Medical with a 7.52% increase [4]
高压氧舱概念涨1.76%,主力资金净流入3股
Sou Hu Cai Jing· 2025-08-05 08:45
Group 1 - The high-pressure oxygen chamber concept increased by 1.76%, ranking 7th among concept sectors, with 7 stocks rising, including Innovation Medical which hit the daily limit, and others like Beiyikang and Weiao Shares rising by 7.40%, 2.86%, and 0.74% respectively [1][2] - The concept sector saw a net inflow of 262 million yuan, with Innovation Medical receiving the highest net inflow of 472 million yuan, followed by Weiao Shares and Yingkang Life with net inflows of 3.37 million yuan and 769,200 yuan respectively [2][3] - The main capital inflow ratios for Innovation Medical, Weiao Shares, and Yingkang Life were 28.82%, 4.53%, and 0.85% respectively, indicating strong investor interest in these stocks [3] Group 2 - The top gainers in the high-pressure oxygen chamber concept included Innovation Medical with a daily increase of 10.03% and a turnover rate of 25.23%, while other stocks like Weiao Shares and Yingkang Life had increases of 2.86% and 0.68% respectively [3] - Conversely, stocks such as Tiedian Heavy Industry, Samsung Medical, and Jinling Pharmaceutical experienced declines of 1.50%, 0.70%, and 0.41% respectively, indicating a mixed performance within the sector [1][4]
今日涨跌停股分析:68只涨停股、2只跌停股,人脑工程概念活跃,创新医疗涨停
Xin Lang Cai Jing· 2025-08-05 07:12
8月5日,A股全天下来共有68只涨停股、2只跌停股。人脑工程概念活跃,创新医疗涨停;PEEK材料概 念走强,中欣氟材、新瀚新材涨停。 连板股方面,*ST亚太9天5板,*ST亚振5连板,中马传动5天4板,倍加洁、文科股份4连板,长城军 工、淳中科技4天3板,东杰智能、*ST宇顺等3连板,上纬新材、良信股份等4天2板,*ST南置3天2板, 山河智能、国机精工等2连板,长飞光纤、马钢股份等涨停。 *ST元成、宏和科技跌停。 ...
人脑工程概念午后异动 创新医疗涨停
Group 1 - The brain engineering concept experienced significant market activity, with several companies in the sector seeing notable stock price increases [1] - Innovation Medical (002173) reached the daily limit increase, indicating strong investor interest [1] - Xiangyu Medical saw a rise of over 15%, reflecting positive market sentiment towards the brain engineering sector [1] Group 2 - Other companies such as Aipeng Medical (300753), Sanbo Brain Science (301293), and Entropy Technology (301330) also experienced slight increases in their stock prices, contributing to the overall positive trend in the industry [1]
突然!多只A股尾盘暴拉!发生了什么?
券商中国· 2025-07-31 12:14
尾盘,再现异动! 7月31日,A股三大指数集体调整,截至今日收盘,沪指下跌1.18%,深证成指跌1.73%,创业板指跌1.66%。从盘面上看,钢铁、煤 炭、有色等前期过热的板块集体大跌,AI、创新药概念股则逆市上涨。 值得关注的是,临近收盘时,创新医疗、爱朋医疗、三博脑科等多只脑机接口概念股直线拉升,创新医疗一度逼近涨停。从消息面来 看,当天下午,脑机接口板块迎来一则利好消息。据报道,国家医保局支持脑机接口等新技术进入临床并收费。 脑机接口概念股尾盘拉升 7月31日,临近A股尾盘时分,多只脑机接口概念股突然直线拉升,创新医疗涨幅一度达到9.62%,爱朋医疗一度涨超9%,三博脑科、 倍益康、熵基科技、南京熊猫等相关概念股均有拉升动作。 | 壳价 叠加 重播 统计 | | 分时 1分钟 5分钟 15分钟 30分钟 60分钟 日线 更多 > | | 画线 F10 | 标记 -自选 返回 | | 创新医疗 002173 | | | | 医疗保健 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 创新医疗 分时 ...
上半年创新药和医疗器械获批数量同比大幅增长
Core Insights - In the first half of this year, China approved 43 innovative drugs and 45 innovative medical devices, representing year-on-year increases of 59% and 87% respectively, indicating that reform policy dividends are transforming into industrial development momentum [1] Regulatory Reforms - Since last year, the National Medical Products Administration (NMPA) has conducted pilot reforms in 11 provincial-level bureaus to optimize the supplementary application process for drugs, reducing the review time for supplementary applications that require inspection from 200 working days to 60 working days [1] - The NMPA is also exploring the completion of clinical trial reviews and approvals for key innovative drugs within 30 working days [1] Product Approvals - In the first half of the year, 70 new pediatric drugs and 21 rare disease drugs were approved [1] Innovation Initiatives - The Ministry of Industry and Information Technology and the NMPA jointly launched an initiative to promote innovation in artificial intelligence medical devices and biomedical materials [1] - The NMPA introduced 10 measures to optimize the full lifecycle supervision to support the innovative development of high-end medical devices, facilitating the market entry of complex and high-difficulty innovative medical devices such as multifocal intraocular lenses and cardiac pulsed field ablation devices [1]
创新医疗管理股份有限公司第七届董事会2025年第一次临时会议决议公告
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:002173 证券简称:创新医疗 公告编号:2025-048 创新医疗管理股份有限公司 第七届董事会2025年第一次临时会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 创新医疗管理股份有限公司(以下简称"公司")第七届董事会于2025年7月30日召开了2025年第一次临 时会议。本次会议以现场和通讯表决相结合的方式召开。会议通知于2025年7月28日以书面形式发出。 本次会议由陈海军董事长主持,应出席董事9名,实际出席董事7名,独立董事姚航平、陈文强以通讯表 决方式对会议所议事项进行了审议和表决。本次会议召开符合《公司法》及公司《章程》的规定,合法 有效。 二、董事会会议审议情况 与会董事就议案进行了审议、表决,以9票赞成、0票反对、0票弃权的表决结果一致通过了如下决议: 1、同意选举陈海军为公司第七届董事会董事长、代表公司执行公司事务的董事,任期自本次会议通过 之日起至本届董事会届满之日止。 2、同意选举陈海军、游向东、姚航平为公司第七届董事会战略委员会成员,其 ...
创新医疗股价微跌0.07% 盘中现快速反弹行情
Sou Hu Cai Jing· 2025-07-30 10:37
风险提示:股市有风险,投资需谨慎。 来源:金融界 创新医疗7月30日收盘报14.24元,较前一交易日下跌0.01元,跌幅0.07%。当日开盘价为14.18元,最高 触及14.56元,最低下探14.08元,成交量为34.51万手,成交金额达4.96亿元。 该公司主营业务涵盖医疗服务领域,涉及浙江区域市场,并与人工智能等前沿技术领域有所关联。创新 医疗当前总市值为62.84亿元,流通市值为59.28亿元。 7月30日早盘交易时段,创新医疗出现快速反弹走势,在9点35分前的5分钟内股价涨幅超过2%,当时报 价14.4元,成交金额3839.77万元。当日主力资金净流出2621.52万元,占流通市值的0.44%。 ...
创新医疗(002173) - 关于聘任公司财务总监的公告
2025-07-30 10:30
创新医疗管理股份有限公司 董 事 会 证券代码:002173 证券简称:创新医疗 公告编号:2025-049 创新医疗管理股份有限公司 关于聘任公司财务总监的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 创新医疗管理股份有限公司(以下简称"公司")于2025年7月30日召开的 第七届董事会2025年第一次临时会议,审议通过了《关于聘任公司财务总监的议 案》。经马建建总裁提名,公司董事会同意聘任杨建荣(简历详见附件)为公司 财务总监,任期自本次董事会审议通过之日起至公司本届董事会届满之日止。马 建建总裁不再代行财务总监职务,在此感谢马建建总裁在公司财务总监职位空缺 期间的勤勉付出。 杨建荣具备履行财务总监职责所必需的专业知识、工作经验,其任职资格及 聘任程序符合《中华人民共和国公司法》《深圳证券交易所股票上市规则》《深圳 证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》以及公司 《章程》等有关规定,不存在法律法规及其他规范性文件规定的不得担任高级管 理人员的情形。 特此公告。 2025 年 7 月 31 日 附:杨建荣简历 1 / 2 ...